| Date Filed | Type | Description |
| 08/17/2023 |
4
| DANSEY ROGER D (President, R&D & CMO) has filed a Form 4 on Seagen Inc.|
Txns:
| Granted 25,747 shares
@ $0
Disposed/sold 1,804 shares
@ $193.8689, valued at
$349.7k
Disposed/sold 6,100 shares
@ $193.8689, valued at
$1.2M
Disposed/sold 2,348 shares
@ $193.8689, valued at
$455.2k
|
|
| 08/17/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/16/2023 |
4
| DANSEY ROGER D (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 12,000 restricted stock units
@ $0
Granted 35,000 options
@ $0.77, valued at
$27k
Granted 26,000 restricted stock units
@ $0
Exercised 19,000 restricted stock units
@ $0 |
|
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/04/2023 |
4
| DANSEY ROGER D (President, R&D & CMO) has filed a Form 4 on Seagen Inc.|
Txns:
| Granted 2,260 shares
@ $0 |
|
| 03/17/2023 |
4
| DANSEY ROGER D (President, R&D & CMO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 10,000 shares
@ $199.8115, valued at
$2M
Exercised 10,000 options to buy
@ $72.64, valued at
$726.4k
|
|
| 02/03/2023 |
4
| DANSEY ROGER D (President, R&D & CMO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 783 shares
@ $138.52, valued at
$108.5k
|
|
| 01/26/2023 |
4
| DANSEY ROGER D (President, R&D & CMO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 10,000 shares
@ $135, valued at
$1.4M
Exercised 10,000 options to buy
@ $72.64, valued at
$726.4k
|
|
| 01/06/2023 |
4
| DANSEY ROGER D (President R&D & CMO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 2,500 shares
@ $135, valued at
$337.5k
Sold 7,500 shares
@ $135, valued at
$1M
Exercised 2,500 options to buy
@ $72.64, valued at
$181.6k
Exercised 7,500 options to buy
@ $72.64, valued at
$544.8k
|
|
| 12/16/2022 |
4
| DANSEY ROGER D (President, Research and Develo) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 597 shares
@ $135, valued at
$80.6k
Sold 9,403 shares
@ $135, valued at
$1.3M
Exercised 597 options to buy
@ $72.64, valued at
$43.4k
Exercised 9,403 options to buy
@ $77.45, valued at
$728.3k
|
|
| 11/14/2022 |
4
| DANSEY ROGER D (See Remarks) has filed a Form 4 on Seagen Inc.|
Txns:
| Granted 275,000 options to buy
@ $137.96, valued at
$37.9M
|
|
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/01/2022 |
4
| DANSEY ROGER D (Interim CEO & CMO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 806 shares
@ $154.4145, valued at
$124.5k
Sold 184 shares
@ $154.4145, valued at
$28.4k
Sold 4,029 shares
@ $154.4145, valued at
$622.1k
|
|
| 08/17/2022 |
4
| DANSEY ROGER D (Interim CEO & CMO) has filed a Form 4 on Seagen Inc.|
Txns:
| Granted 44,625 shares
@ $0
Sold 2,406 shares
@ $170.2151, valued at
$409.5k
Sold 1,848 shares
@ $170.2151, valued at
$314.6k
|
|
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2022 |
4
| DANSEY ROGER D (Chief Medical Officer) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 787 shares
@ $144.3186, valued at
$113.6k
Sold 652 shares
@ $144.15, valued at
$94k
|
|
| 02/04/2022 |
4
| DANSEY ROGER D (Chief Medical Officer) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 739 shares
@ $137.58, valued at
$101.7k
Sold 703 shares
@ $136.14, valued at
$95.7k
|
|
| 01/05/2022 |
4
| DANSEY ROGER D (Chief Medical Officer) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 3,470 shares
@ $152.5819, valued at
$529.5k
Sold 1,735 shares
@ $152.5819, valued at
$264.7k
|
|
| 12/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2021 |
4
| DANSEY ROGER D (Chief Medical Officer) has filed a Form 4 on Seagen Inc.|
Txns:
| Granted 129 shares
@ $166.22, valued at
$21.4k
Granted 3,453 shares
@ $166.22, valued at
$574k
|
|
| 09/02/2021 |
4
| DANSEY ROGER D (Chief Medical Officer) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 3,701 shares
@ $167.5155, valued at
$620k
Sold 741 shares
@ $167.5155, valued at
$124.1k
Sold 169 shares
@ $167.5155, valued at
$28.3k
|
|
| 06/21/2021 |
4
| DANSEY ROGER D (Chief Medical Officer) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 25,109 shares
@ $152.2177, valued at
$3.8M
|
|
| 05/17/2021 |
4
| DANSEY ROGER D (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Granted 54,000 options
@ $6.23, valued at
$336.4k
Granted 36,000 restricted stock units
@ $0 |
|
| 05/17/2021 |
3
| DANSEY ROGER D (Director) has filed a Form 3 on INOVIO PHARMACEUTICALS, INC. |
| 02/04/2021 |
4
| DANSEY ROGER D (Chief Medical Officer) has filed a Form 4 on Seagen Inc.|
Txns:
| Disposed/sold 728 shares
@ $163.97, valued at
$119.4k
|
|
| 11/05/2020 |
4
| DANSEY ROGER D (Chief Medical Officer) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 7,302 shares
@ $177, valued at
$1.3M
Sold 359 shares
@ $177.065, valued at
$63.6k
|
|
| 09/02/2020 |
4
| DANSEY ROGER D (Chief Medical Officer) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Sold 3,701 shares
@ $155.6942, valued at
$576.2k
Sold 741 shares
@ $155.6942, valued at
$115.4k
Sold 169 shares
@ $155.6942, valued at
$26.3k
|
|
| 08/17/2020 |
4
| DANSEY ROGER D (Chief Medical Officer) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Granted 13,192 shares
@ $0
Sold 450 shares
@ $157.7912, valued at
$71k
Granted 636 options to buy
@ $161.82, valued at
$102.9k
Granted 32,073 options to buy
@ $161.82, valued at
$5.2M
|
|
| 06/19/2020 |
4
| DANSEY ROGER D (Chief Medical Officer) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Sold 900 shares
@ $157.74, valued at
$142k
Sold 300 shares
@ $158.47, valued at
$47.5k
Sold 962 shares
@ $160.1, valued at
$154k
|
|
|